Paying users zone. Data is hidden behind 
.
Get 1-month access to Pfizer Inc. for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Pfizer Inc. (PFE)
Analysis of Inventory
Advanced level
Accounting Policy on Inventory
Pfizer carries inventories at the lower of cost or net realizable value. The cost of finished goods, work in process and raw materials is determined using average actual cost. Pfizer regularly reviews the inventories for impairment and reserves are established when necessary.
Source: 10-K (filing date: 2019-02-28).
Inventory Disclosure
Pfizer Inc., balance sheet: inventory
US$ in millions
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Finished goods | |
|
|
|
|
||||||
| Work in process | |
|
|
|
|
||||||
| Raw materials and supplies | |
|
|
|
|
||||||
| Inventories | |
|
|
|
|
Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).
| Item | Description | The company |
|---|---|---|
| Inventories | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. | Pfizer Inc.’s inventories increased from 2016 to 2017 but then slightly decreased from 2017 to 2018. |